Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-s ...

Daniel Skovronsky, the president of Lilly Research Laboratories and Lilly Immunology, stated that Omvoh offers more patients a treatment option that can provide long-term disease control and ...

Daniel Skovronsky, the president of Lilly Research Laboratories and Lilly Immunology, stated that Omvoh offers more patients a treatment option that can provide long-term disease control and ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Jan Lundberg, executive vice president of science and technology and president of Lilly Research Laboratories, said: "We are pleased to be expanding our alliance with AstraZeneca to further build ...

Analysts have deemed LLY stock a “Strong Buy,” with an average target price of $984.29, indicating an upside potential of 12.1% from Friday’s closing price. Among the 24 analysts covering the stock, ...

Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...

The results add to evidence from animal studies and reports that people are finding the drugs helpful to manage cravings, not ...

Philanthropy helped build artificial intelligence as a nonprofit research field. But as costs soar and corporations take over ...

and president of Lilly Research Laboratories. At Lilly, Paul helped develop the company’s mental health blockbusters, Zyprexa and Cymbalta, and helped oversee development of muscarinic ...